🕵️ Novavax Inc ($NVAX)
SEC insider & ownership activity, last 12 months · CIK 1000694 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Impairment (2.06), Oct 17, 2025.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Himanshu H. Shah | 9.0% | 13D | May 14, 2026 | filing ↗ | |
| SHAH Capital Management | 8.9% | 13D | May 14, 2026 | filing ↗ | |
| SHAH Capital Opportunity Fund LP | 8.5% | 13D | May 14, 2026 | filing ↗ | |
| Blackrock, Inc. | 8.4% | 13G | Feb 5, 2025 | filing ↗ | |
| Himanshu H. Shah | 7.3% | 13D | Oct 13, 2025 | filing ↗ | |
| State Street Corporation | 5.9% | 13G | Feb 9, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 30, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Ruxandra Draghia Akli | $235K | May 27, 2026 | filing ↗ |
| Ruxandra Draghia Akli | $296K | May 7, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Shareholder vote (5.07) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Material agreement (1.01) | Jan 15, 2026 | filing ↗ |
| Earnings (2.02) | Jan 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 3, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 17, 2025 | filing ↗ |
| Impairment (2.06) | Oct 17, 2025 | filing ↗ |
| Other events (8.01) | Oct 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 17, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 1, 2025 | filing ↗ |
| Other events (8.01) | Oct 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 1, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 27, 2025 | filing ↗ |
| New financial obligation (2.03) | Aug 27, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 27, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 27, 2025 | filing ↗ |
| Other events (8.01) | Aug 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 27, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 20, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 20, 2025 | filing ↗ |